ICR has acquired Consilium Strategic Communications, the London-based healthcare communications and investor relations firm.

The deal, which caps about a decade of joint venture activity between the firms, will result in the combination of Consilium’s 45 staffers with ICR’s Westwicke and its more than 70 healthcare pros to create an entity that serves nearly 200 clients.

The Consilium acquisition provides ICR its first official on-the-ground presence in Europe, broadening its global footprint from North America and the Asia Pacific regions.

Tom Ryan, ICR CEO, said: “Consilium has long been recognized as the preeminent healthcare communications and advisory firm across Europe and our years of collaboration have allowed us to learn first-hand what makes them so unique.”

Mary-Jane Elliott, managing partner, and Amber Fennell, senior partner, launched Consilium in 2013.

They will join the ICR healthcare leadership team that includes Mark Klausner and Bob East (IR); and Terri Clevenger and Michael O’Brien (PR).

"I am excited by our next phase of growth as part of ICR, which is backed by two leading global private equity firms—CDPQ and Investcorp, and what opportunities this offers, particularly in the US, to our clients and colleagues, including offering a broader range of capabilities,” said Elliott.

Noting that Consilium has shared many clients with ICR over the years, Elliott believes it’s "the right time to deepen that relationship, which coincides with hopefully the continued re-opening of the capital markets, and we look forward to what we can accomplish together.”